Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecules and Cells

• Publication date

  2009-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molcel.2009.04.001PMID 19450526PMCID PMC2723750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CCCTC-binding Factor Activates PARP-1 Affecting DNA Methylation Machinery

  2008cited by this paper
• Epigenetics at the epicenter of modern medicine.

  2008cited by this paper
• Genetics and epigenetics of the multifunctional protein CTCF.

  2008cited by this paper
• Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation.

  2008cited by this paper
• pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene.

  2007cited by this paper
• Regulation of histone methylation by demethylimination and demethylation

  2007cited by this paper
• The Polycomb group protein EZH2 directly controls DNA methylation

  2007cited by this paper
• The epigenomics of cancer.

  2007cited by this paper
• Nucleolin: a multiFACeTed protein.

  2007cited by this paper
• The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells.

  2007cited by this paper
• Sp1 Is Essential for p16INK4a Expression in Human Diploid Fibroblasts during Senescence

  2007cited by this paper
• Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF.

  2007cited by this paper
• We gather together: insulators and genome organization.

  2007cited by this paper
• Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2'-deoxycytidine treatment.

  2007cited by this paper
• Implication of Polycomb Members Bmi-1, Mel-18, and Hpc-2 in the Regulation of p16INK4a, p14ARF, h-TERT, and c-Myc Expression in Primary Breast Carcinomas

  2006cited by this paper
• CTCF Mediates Interchromosomal Colocalization Between Igf2/H19 and Wsb1/Nf1

  2006cited by this paper
• Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state.

  2006influential reference
• Patterning chromatin: form and function for H2A.Z variant nucleosomes.

  2006cited by this paper
• A Topoisomerase IIß-Mediated dsDNA Break Required for Regulated Transcription

  2006cited by this paper
• p16INK4a Prevents Centrosome Dysfunction and Genomic Instability in Primary Cells

  2006cited by this paper
• The Polycomb group protein EZH2 directly controls DNA methylation

  2006cited by this paper
• Oncogenic activity of Cdc6 through repression of the INK4/ARF locus

  2006cited by this paper
• Faculty Opinions recommendation of A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription.

  2006cited by this paper
• The regulation of INK4/ARF in cancer and aging.

  2006cited by this paper
• Tumor Suppressor p16INK4A Regulates Polycomb-mediated DNA Hypermethylation in Human Mammary Epithelial Cells*

  2006cited by this paper
• p16INK4a promoter methylation and protein expression in breast fibroadenoma and carcinoma

  2005cited by this paper
• Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP).

  2005influential reference
• Distinct Hypermethylation Profile of Primary Breast Cancer Is Associated with Sentinel Lymph Node Metastasis

  2005cited by this paper
• Chromatin Inactivation Precedes De Novo DNA Methylation during the Progressive Epigenetic Silencing of the RASSF1A Promoter

  2005cited by this paper
• Role of CTCF Binding Sites in the Igf2/H19 Imprinting Control Region

  2004cited by this paper
• DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter

  2004cited by this paper
• Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation

  2004influential reference
• CTCF tethers an insulator to subnuclear sites, suggesting shared insulator mechanisms across species.

  2004cited by this paper
• A systematic profile of DNA methylation in human cancer cell lines.

  2003cited by this paper
• Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia.

  2003cited by this paper
• CTCF functions as a critical regulator of cell-cycle arrest and death after ligation of the B cell receptor on immature B cells

  2003cited by this paper
• Chromatin (dis)organization and cancer: BUR-binding proteins as biomarkers for cancer.

  2002cited by this paper
• Dependence of histone modifications and gene expression on DNA hypermethylation in cancer.

  2002cited by this paper
• Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence

  2001cited by this paper
• CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus

  2000cited by this paper
• The protein CTCF is required for the enhancer blocking activity of vertebrate insulators.

  1999cited by this paper
• The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

  1999cited by this paper
• DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2'-deoxycytidine.

  1999cited by this paper
• Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.

  1998cited by this paper
• Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation

  1998influential reference
• Frequent hypermethylation of p16 and p15 genes in multiple myeloma.

  1997cited by this paper
• E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.

  1995cited by this paper
• CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine.

  1995cited by this paper

• Epigenetic Regulation of Higher-Order Chromatin Structure (HOCS) and Its Implication in Human Diseases

  2026cites this paper
• Senescence-associated and immune-related 9p21.3 locus genes in colorectal cancer: epigenetic architecture, molecular landscape and therapeutic possibilities.

  2026cites this paper
• Loss of DHX36/G4R1, a G4 resolvase, drives genome instability and regulates innate immune gene expression in cancer cells

  2025cites this paper
• Interrogating the regulatory epigenome of cellular senescence

  2025cites this paper
• Differential Expression of Lamins and Modulation of Chromatin Architecture in Carcinogenesis: tous pour un et un pour tous.

  2025cites this paper
• The interplay of p16INK4a and non-coding RNAs: bridging cellular senescence, aging, and cancer

  2025cites this paper
• Deciphering the mechanisms of PARP inhibitor resistance in prostate cancer: Implications for precision medicine.

  2025cites this paper
• Whole genome bisulfite sequencing reveals epigenetic drivers of chronic chlorpyrifos exposure induced liver cell neoplasia.

  2025cites this paper
• Loss of DHX36/G4R1, a G4 resolvase, drives genome instability and regulates innate immune gene expression in cancer cells

  2025cites this paper
• Interplay between epigenetics and metabolism controls cancer stem cell plasticity

  2024cites this paper
• Estrogen-induced chromatin looping changes identify a subset of functional regulatory elements

  2024cites this paper
• Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy

  2024cites this paper
• Epigenotoxicity: Decoding the epigenetic imprints of genotoxic agents and their implications for regulatory genetic toxicology.

  2024cites this paper
• Ionizing radiation induces vascular smooth muscle cell senescence through activating NF-κB/CTCF/p16 pathway.

  2023cites this paper
• The epigenetic regulation of cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence.

  2023cites this paper
• CTCF and Its Multi-Partner Network for Chromatin Regulation

  2023cites this paper
• Landscape of chromatin remodeling gene alterations in endometrial carcinoma.

  2023cites this paper
• Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance

  2023cites this paper
• Bioinformatic Analysis of Recurrent Genomic Alterations and Corresponding Pathway Alterations in Ewing Sarcoma

  2023cites this paper
• CTCF deletion alters the pluripotency and DNA methylation profile of human iPSCs

  2023cites this paper
• Epigallocatechin Gallate (EGCG), an Active Phenolic Compound of Green Tea, Inhibits Tumor Growth of Head and Neck Cancer Cells by Targeting DNA Hypermethylation

  2023cites this paper
• Involvement of CCCTC-binding factor in epigenetic regulation of cancer

  2023cites this paper
• Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer

  2022cites this paper
• Untangling the roles of TOP2A and TOP2B in transcription and cancer

  2022influential citation
• A Novel Necroptosis-Associated IncRNAs Signature for Prognosis of Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• Can abnormal chromatin folding cause high-penetrance cancer predisposition?

  2022cites this paper
• Nickel-induced alterations to chromatin structure and function.

  2022cites this paper
• Epigenetic Insights on PARP-1 Activity in Cancer Therapy

  2022cites this paper
• CTCF: A misguided jack-of-all-trades in cancer cells

  2022cites this paper
• Widespread allele-specific topological domains in the human genome are not confined to imprinted gene clusters

  2022cites this paper
• A Novel Signature of Necroptosis-Associated Genes as a Potential Prognostic Tool for Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• DNA Methylation Malleability and Dysregulation in Cancer Progression: Understanding the Role of PARP1

  2022cites this paper
• The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis

  2022cites this paper
• The function of brother of the regulator of imprinted sites in cancer development

  2022cites this paper
• 3D chromatin remodeling potentiates transcriptional programs driving cell invasion

  2021cites this paper
• Targeted core-shell nanoparticles for precise CTCF gene insert in treatment of metastatic breast cancer.

  2021cites this paper
• Encounters in Three Dimensions: How Nuclear Topology Shapes Genome Integrity

  2021cites this paper
• Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy

  2021cites this paper
• CRISPR/Cas9 in epigenetics studies of health and disease.

  2021cites this paper
• Transcription analysis of a histones modifiers panel coupled with critical tumor suppressor genes displayed frequent changes in patients with AML.: mRNA levels of histones modifiers and TSGs in AML.

  2021cites this paper
• Three-Dimensional Genome Organization in Breast and Gynecological Cancers: How Chromatin Folding Influences Tumorigenic Transcriptional Programs

  2021cites this paper
• Targeted degradation of CTCF decouples local insulation of Targeted degradation of CTCF decouples local insulation of chromosome domains from higher-order genomic chromosome domains from higher-order genomic compartmentalization [preprint] compartmentalization

  2021cites this paper
• Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells—Relevance for Understanding (Germ Cell) Tumorigenesis

  2021cites this paper
• Transcription Analysis of a Histones Modi ers Panel Coupled with Tumor Suppressor Genes Displayed Frequent Changes in Acute Myeloid Leukemia-Related Genes

  2020cites this paper
• Dynamic regulation of CTCF stability and sub-nuclear localization in response to stress

  2020influential citation
• Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis

  2020cites this paper
• An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer

  2020cites this paper
• Targeted intragenic demethylation initiates chromatin rewiring for gene activation

  2020cites this paper
• Cockayne syndrome group A and B proteins function in rRNA transcription through nucleolin regulation.

  2020cites this paper
• Title: Targeted intragenic demethylation initiates chromatin rewiring for gene activation

  2020cites this paper
• CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis

  2020cites this paper
• CTCF loss mediates unique DNA hypermethylation landscapes in human cancers

  2020cites this paper
• NAD Modulates DNA Methylation and Cell Differentiation

  2020cites this paper
• Systematical identification of cell-specificity of CTCF-gene binding based on epigenetic modifications

  2020cites this paper
• Alu retrotransposons modulate Nanog expression through dynamic changes in regional chromatin conformation via aryl hydrocarbon receptor

  2020cites this paper
• Clinical Significance of P16 Gene Methylation in Lung Cancer.

  2020cites this paper
• Cellular Senescence and Tumor Promotion

  2020cites this paper
• MeCP2 and Chromatin Compartmentalization

  2020cites this paper
• Title: Targeted intragenic demethylation initiates chromatin rewiring for gene activation

  2020cites this paper
• RNA Interactions Are Essential for CTCF-Mediated Genome Organization.

  2019cites this paper
• Endometriosis-associated ovarian cancer: What have we learned so far?

  2019cites this paper
• CTCF cooperates with CtIP to drive homologous recombination repair of double-strand breaks

  2019cites this paper
• Epigenetics of Aging and Cancer: A Comprehensive Look

  2019cites this paper
• RNA interactions with CTCF are essential for its proper function

  2019cites this paper
• Genomic Applications and Insights in Unravelling Cancer Signalling Pathways

  2019cites this paper
• Poly ( ADP-ribosyl ) ation is involved in the epigenetic control of TET 1 gene transcription

  2019cites this paper
• The Diagnostic and Therapeutic Potential of the Epigenetic Modifications of Lung Cancer–Related Genes

  2019cites this paper
• Modified CDKN2B (p15) and CDKN2A (p16) DNA methylation profiles in urban pesticide applicators

  2019cites this paper
• Role of PARP-catalyzed ADP-ribosylation in the crosstalk between DNA strand breaks and epigenetic regulation.

  2019cites this paper
• Topoisomerase VI participates in an insulator-like function that prevents H3K9me2 spreading

  2019cites this paper
• Epigenetic Regulation of Skin Cells in Natural Aging and Premature Aging Diseases

  2018cites this paper
• Coordinated transcription of ANRIL and P16 genes is silenced by P16 DNA methylation.

  2018cites this paper
• Molecular Lesions of Insulator CTCF and Its Paralogue CTCFL (BORIS) in Cancer: An Analysis from Published Genomic Studies

  2018cites this paper
• CTCF Expression is Essential for Somatic Cell Viability and Protection Against Cancer

  2018cites this paper
• FAST-1 antisense RNA epigenetically alters FXN expression

  2018cites this paper
• From association to mechanism in complex disease genetics: the role of the 3D genome

  2018cites this paper
• b-globin gene transfer to human bone marrow for sickle cell disease

  2018cites this paper
• Investigating the conformational response of the Sortilin receptor upon binding endogenous peptide- and protein ligands by HDX-MS

  2018cites this paper
• Poly(ADP-ribose) polymerase activity and inhibition in cancer.

  2017cites this paper
• The β-NAD+ salvage pathway and PKC-mediated signaling influence localized PARP-1 activity and CTCF Poly(ADP)ribosylation

  2017influential citation
• CTCF, Cohesin, and Chromatin in Human Cancer

  2017cites this paper
• Therapeutic Targeting of Poly(ADP‐Ribose) Polymerase‐1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities

  2017cites this paper
• Targeted Degradation of CTCF Decouples Local Insulation of Chromosome Domains from Genomic Compartmentalization.

  2017cites this paper
• The Role of p16INK4a Pathway in Human Epidermal Stem Cell Self-Renewal, Aging and Cancer

  2017cites this paper
• A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro

  2017cites this paper
• MeCP2 and CTCF: enhancing the cross-talk of silencers.

  2017cites this paper
• Genome Organization Drives Chromosome Fragility.

  2017cites this paper
• Targeted degradation of CTCF decouples local insulation of chromosome domains from higher-order genomic compartmentalization

  2017cites this paper
• PARP1 orchestrates epigenetic events setting up chromatin domains.

  2017cites this paper
• Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer

  2017cites this paper
• Epigenetics of human diseases and scope in future therapeutics

  2017cites this paper
• CCCTC-binding factor inhibits breast cancer cell proliferation and metastasis via inactivation of the nuclear factor-kappaB pathway

  2017cites this paper
• New insights on the role of DNA methylation from a global view.

  2017cites this paper
• CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic

  2017cites this paper
• CCCTC-binding factor inhibits breast cancer cell proliferation and metastasis via inactivation of the nuclear factor-kappaB pathway.

  2017cites this paper
• Global inhibition of transcription causes an increase in histone H2A.Z incorporation within gene bodies

  2017cites this paper
• CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair

  2017cites this paper
• CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression

  2016cites this paper
• A gain-of-function senescence bypass screen identifies the homeobox transcription factor DLX2 as a regulator of ATM–p53 signaling

  2016cites this paper
• The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms

  2016cites this paper